Jesus Maria Banales

34PUBLICATIONS
232CO-AUTHORS
Gene and molecular therapyCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|May 04, 2026
Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray Genotyping.

|Apr 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

|Mar 30, 2026
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis.

Jörn M Schattenberg, Jesus M Banales, Gideon Hirschfield

|Dec 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Nov 29, 2025
Association of Epigenetic Aging Biomarkers With Risk of MASLD-Related HCC.

Alani Perkin, Sebastian M Armasu, Winnie Z Fan

|Nov 18, 2025
Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group.

Carla Fiorella Murillo Perez, Shannon M Vandriel, Emmanuel M Gonzales

Pageof 6

Frequent Collaborators

11 joint publications

Pedro M Rodrigues

8 joint publications

Jesper B Andersen

6 joint publications

Luis Bujanda

5 joint publications

Rocio I R Macias